Picture of Deepverge logo

DVRG Deepverge Share Price

0.000.00%
gb flag iconLast trade - 00:00
IndustrialsHighly SpeculativeMicro Cap

Momentum

Relative Strength (%)
1m-75.01%
3m-90.69%
6m-91.06%
1yr-98.62%
Volume Change (%)
10d/3mn/a
Price vs... (%)
52w Highn/a
50d MAn/a
200d MAn/a

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-11.65%
Return on Equity-10.27%
Operating Margin-24.88%

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202231st Dec 2023
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2022 / 2023

Blurred out image of Deepverge EPS forecast chart

Profile Summary

Deepverge PLC is an Ireland-based vertically integrated company. The Company provides core skin and human testing technology. The Company is engaged in collaborating technology platforms with partners in artificial intelligence (AI), clinical research, medical device, life science and environmental science. Its Labskin delivers human skin microbiology services to support product R&D activities in the cosmetic, personal care, medical device and pharmaceutical sectors. The Labskin model is a 3D human skin equivalent that incorporates vital biological components to model normal skin function. It allows skin-care, health-care, nutritional, pharmaceutical manufacturers and cosmetic companies to test consumer products on human-like skin in a real-world environment with full access to multiple partner technologies.

Directors

Last Annual
December 31st, 2021
Last Interim
June 30th, 2022
Incorporated
May 28th, 2016
Public Since
January 1st, 1970
No. of Employees
73
Sector
Professional & Commercial Services
Industry
Industrials
Exchange
gb flag iconLondon Stock Exchange
Shares in Issue
760,456,378

DVRG Share Price Performance

Upcoming Events for DVRG

Similar to DVRG

Picture of ADVFN logo

ADVFN

gb flag iconLondon Stock Exchange

Picture of Andrews Sykes logo

Andrews Sykes

gb flag iconLondon Stock Exchange

Picture of Anexo logo

Anexo

gb flag iconLondon Stock Exchange

Picture of Aquila Services logo

Aquila Services

gb flag iconLondon Stock Exchange

FAQ